$ICL

ICL Financials: Revenue Breakdown, Margins & Competitor Comparison

The article analyzes ICL Group Ltd.'s financial performance, focusing on its revenue breakdown, profitability margins, and competitor comparison within the Agricultural Chemicals industry. It highlights that Phosphate Solutions is ICL's largest revenue contributor, and the company maintains a gross margin of 27.51% despite negative operating and net margins. ICL's financial metrics are benchmarked against industry peers like MOS and SMG to provide context for its market valuation.

Original reporting
Published Apr 9, 2026, 2:02 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Apr 9, 2026, 2:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
ICL Financials: Revenue Breakdown, Margins & Competitor Comparison — source image
Decision brief

The 30-second read

$ICLNeutralLow
01

Why it matters

The financials suggest resilience but highlight margin challenges, which could influence investor sentiment.

02

Market read

The article provides insights into ICL's financial health relative to industry peers, relevant for sector investors.

03

What to watch

Potential upcoming product launches or market expansions not discussed could alter outlook.

Timing: Long-term perspective; short-term trading impact minimal.

Background

ICL Group Ltd. is a key player in the agricultural chemicals industry, with diversified revenue streams.

Company-level read

Ticker impact

$ICLNeutralMedium confidence
Context

Primary focus of the article, significant impact on related sectors.

Expected impact

Limited immediate price movement expected; potential for slight appreciation if revenue stability persists.

Evidence & confidence

Financial metrics show stability but margins are below industry averages, indicating cautious outlook. No significant catalysts identified for sharp price changes.

Market effects

Potential pressure on agricultural chemicals sector margins; investor focus on profitability metrics.

Limited regional impact; company operates globally but data specific to regional markets is limited.

Moderate; as a major player in agricultural chemicals, ICL's performance influences global sector sentiment.

Counterpoint

The company may be undervalued if margins improve due to operational efficiencies or market share gains.

Key entities

  • ICL Group Ltd.

    A global leader in specialty minerals and chemicals.

  • MOS

    Mosaic Company, a major competitor in the phosphate industry.

  • SMG

    Sino Agro Food, a peer in the agricultural sector.

Related articles

$ICLMed

ICL reports Q2 2026 sales higher by 17% to $2.1 billion

ICL reported Q2 2026 sales of $2.1 billion, up 17% from $1.8 billion a year earlier, citing stronger pricing and demand. Operating income rose to $266 million from $181 million, and net income to $137 million from $93 million. Adjusted EBITDA was $448 million. ICL reiterated FY2026 adjusted EBITDA guidance of $1.5 billion to $1.7 billion and potash volumes of 4.5 to 4.7 million metric tons.

$ICLMedAI 8/10

ICL (ICL) Q2 2026 Earnings Call Transcript

ICL Group reported Q2 2026 sales of $2.1 billion, up 17%, and adjusted EBITDA of $448 million, up 28%, citing higher potash, bromine and phosphate prices. Adjusted net income rose 35% to $149 million, and adjusted EPS rose 33% to $0.12. Free cash flow was $94 million. Full-year 2026 EBITDA guidance was reiterated at $1.5 billion to $1.7 billion.

$ICLMedAI 8/10

ICL Group LTD: ICL Reports Second Quarter 2026 Results

ICL Group (NYSE: ICL) reported Q2 2026 results for the quarter ended June 30, 2026. Consolidated sales rose to $2.1 billion (+17% Y/Y). Operating income increased to $266 million from $181 million, and net income attributable to shareholders rose to $137 million from $93 million. ICL reiterated FY2026 adjusted EBITDA guidance of $1.5B to $1.7B and expects potash volumes of 4.5 to 4.7 million metric tons.

$RKLBMedAI 8/10

Rocket Lab Just Unveiled a Game-Changing Technology Worth Watching

Rocket Lab (RKLB) said it won a $397 million U.S. Space Force contract to develop, launch, and operate multiple Flatellites for the SB-AMTI program. Flatellites are slimmer, stackable satellites intended to increase deployments per launch and integrate with Rocket Lab’s Neutron rocket. The article cites analyst forecasts for revenue rising from $602M (2025) to $1.7B (2028).